Thomas Owen
About Thomas Owen
Thomas Owen's Role at Opvia
Thomas Owen works in the pharmaceuticals sector at Opvia. His role involves significant contributions to the implementation and optimization of electronic batch records, a critical component in modern pharmaceutical manufacturing processes. Owen has written extensively about the benefits and best practices of integrating electronic batch records across various industries, including biopharmaceuticals and cell therapy manufacturing.
Research on Electronic Batch Records by Thomas Owen
Thomas Owen has authored several articles focusing on the implementation and benefits of electronic batch records. He discusses how these records enhance manufacturing yield and process efficiency by providing detailed documentation. His work also emphasizes the importance of automated data collection in the creation of digital twins for bioprocesses, contributing to more precise and efficient manufacturing practices in the biopharmaceutical industry.
Generative AI in Biotechnology: Insights by Thomas Owen
Thomas Owen has explored the use of generative AI in biotechnology. His research focuses on the potential of generative AI to create new data sets and predict protein structures, which may significantly advance drug discovery and development processes. This exploration places Owen at the forefront of integrating cutting-edge AI technologies in biotechnology.
Thomas Owen on Drug Efficacy and Safety Optimization
In his analysis of dose responses from candidate compounds, Thomas Owen aims to optimize drug efficacy and safety. He has compared EC50 and LogP values in drug discovery to identify compounds with the desired pharmacological properties. Furthermore, Owen has assessed the impact of drug compounds on hormone levels, which is crucial for understanding their effects on endocrine function and overall drug safety.
Cell Therapy Manufacturing Documentation: Thomas Owen's Perspective
Thomas Owen has discussed the critical role of batch records in cell therapy manufacturing. He emphasizes the importance of detailed documentation to ensure the consistency, safety, and effectiveness of cell therapies. His insights are aimed at improving the manufacturing processes and outcomes in this rapidly advancing field.